IDEA Collider

Using AI In Drug Discovery With Andrew Hopkins

Episode Notes

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Andrew Hopkins, the Founder & CEO of Exscientia, as he talks to us about the use of AI in drug discovery.

In the episode, we delve into Andrew’s journey of developing better drug discovery methods, applying data mining in drug discovery, and the value of data integration in the pharmaceutical industry. Additionally, he expounds on what AI drugs look like and future plans for Exscientia.

Tune in!

During this episode, you will learn about;

[01:12] Introducing Andrew Hopkins & his journey to his current role

[06:27] Applying data mining approach & machine learning

[12:10] What Andrew saw that others were not seeing

[19:06] The value of data integration

[22:02] The role of asking questions & finding answers in tech or data

[26:46] How Hopkins addresses being referred to as the AI discovery group

[33:08] Active learning approaches

[39:06] What an AI drug looks like & what it’s better at

[42:17] The future of AI drugs & Exscientia future plans in establishing clinics

[46:34] What do the next couple of years look like regarding solutions Andrew wished he had 5-10 years ago?